SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-91290"
 

Sökning: id:"swepub:oai:DiVA.org:uu-91290" > St John's wort decr...

St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism

Tannergren, Christer (författare)
Uppsala universitet,Institutionen för farmaci
Engman, Helena (författare)
Uppsala universitet,Institutionen för farmaci
Knutson, Lars (författare)
Uppsala universitet,Institutionen för farmaci
visa fler...
Hedeland, Mikael (författare)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi
Bondesson, Ulf (författare)
Uppsala universitet,Kemiska institutionen
Lennernäs, Hans (författare)
Uppsala universitet,Institutionen för farmaci
visa färre...
 (creator_code:org_t)
Springer Science and Business Media LLC, 2004
2004
Engelska.
Ingår i: Clinical Pharmacology and Therapeutics. - : Springer Science and Business Media LLC. - 0009-9236 .- 1532-6535. ; 75:4, s. 298-309
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • OBJECTIVE:Our objective was to investigate the inducing effect of repeated oral administration of St John's wort on the jejunal transport and presystemic extraction of R- and S-verapamil in humans.METHODS:Jejunal single-pass perfusion experiments with 120-mg/L (244 micromol/L) R-/S-verapamil were performed in 8 healthy male volunteers for 100 minutes before and after 14 days of oral treatment with St John's wort (300 mg 3 times a day). The enantiomers of verapamil and the cytochrome P450 (CYP) 3A4-formed metabolite norverapamil in perfusate and plasma were quantified by chiral HPLC with fluorescence and tandem mass spectrometry detection, respectively.RESULTS:St John's wort did not affect the jejunal permeability or the fraction absorbed of either R- or S-verapamil. The values for area under the plasma concentration-time curve (AUC) for R- and S-verapamil decreased by 78% and 80%, respectively (P <.0001). The corresponding decreases in the maximum concentration were 76% and 78%, respectively (P <.0001), whereas the terminal half-life did not change significantly for any of the enantiomers. The AUC for R-verapamil was 6 times higher than that for S-verapamil in the control phase, and St John's wort did not change this ratio. The AUC values for R- and S-norverapamil decreased by 51% (P <.01) and 63% (P <.0001), respectively.CONCLUSIONS:Repeated administration of St John's wort significantly decreased the bioavailability of R- and S-verapamil. This effect is caused by induction of first-pass CYP3A4 metabolism, most likely in the gut, because the jejunal permeability and the terminal half-life were unchanged for both enantiomers.

Nyckelord

Administration; Oral
Adult
Analysis of Variance
Area Under Curve
Biological Availability
Dose-Response Relationship; Drug
Drug Administration Schedule
Drug Interactions
Half-Life
Human
Hypericum
Intestinal Absorption/*drug effects
Jejunum/drug effects/physiology
Male
Perfusion
Phytotherapy
Plant Preparations/*administration & dosage
Sensitivity and Specificity
Support; Non-U.S. Gov't
Verapamil/administration & dosage/*pharmacokinetics

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy